Home › NDC Lookup › RxCUI directory › RxCUI 2049127

Binimetinib 15 MG Oral Tablet — RxCUI 2049127

RxNorm drug concept · Semantic clinical drug
RxCUI 2049127 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2049127
Official nameBinimetinib 15 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped1
Package NDCs mapped2
Reported Medicaid activity (SDUD)1,054 prescriptions · 16 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Binimetinib: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • That's a great question. Mektowi and encorafenib target two different 'switches' in the same signaling chain that drives your cancer's growth. Blocking the chain at two points at o...
  • Why does my doctor say I have to take two medicines — Mektovi and encorafenib — together?
  • Nausea, fatigue, loose stools, and mild belly discomfort are common and often manageable with supportive care — keep your care team in the loop, but these aren't usually emergencie...
  • What side effects should I just manage at home versus call the doctor about right away?
📖 Read our full Binimetinib guide →

🕸️ Concept Web — How Binimetinib 15 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Binimetinib 15 MG Oral Tablet RxCUI 2049127

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Binimetinib 2049122
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Mektovi 2049128
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Binimetinib Oral Tablet 2049126
    • Binimetinib Oral Product 2049124
    • Binimetinib Pill 2049125
    • Binimetinib Oral Tablet [Mektovi] 2049130
    • Mektovi Oral Product 2049131
    • Mektovi Pill 2049132
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Binimetinib 15 MG SCDC · 2049123
  • Binimetinib Oral Tablet SCDF · 2049126
  • Binimetinib Oral Product SCDG · 2049124
  • Binimetinib Pill SCDG · 2049125

Brand-Name Concepts

  • Binimetinib 15 MG Oral Tablet [Mektovi] SBD · 2049133
  • Binimetinib 15 MG [Mektovi] SBDC · 2049129
  • Binimetinib Oral Tablet [Mektovi] SBDF · 2049130
  • Mektovi Oral Product SBDG · 2049131
  • Mektovi Pill SBDG · 2049132
  • Mektovi BN · 2049128

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 2049127 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
70255-0010-02 1 BOTTLE in 1 CARTON (70255-010-02) / 180 TABLET, FILM COAT... MEKTOVI Array BioPharma Inc. 2018-06-27
70255-0010-03 90 TABLET, FILM COATED in 1 BOTTLE (70255-010-03) MEKTOVI Array BioPharma Inc. 2018-06-27
Observed labelers: Array BioPharma Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.